These compounds may interact with:
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Potentially involved in: acquired metabolic disease; conduct disorder; kidney cancer; carcinoma; bipolar disorder; schizophrenia; huntington's disease; choreatic disease; parkinson's disease; multiple system atrophy; alcoholic intoxication, chronic; psychotic disorders; nonorganic psychosis; adult high grade glioma; astrocytic glioma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; breast cancer; cutaneous lupus erythematosus; ependymoma
Disease data sourced from Pharos.